Immunosuppressive treatment in patient with pure red cell aplasia associated with chronic myelomonocytic leukemia: Harm or benefit?

International Journal of Hematology

Volumn 90, Issue 5, 2009, Pages 597-600

  Tanna, Saloni ^a   Ustun, Celalettin ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Acute myelogenous leukemia; Chronic myelomonocytic leukemia; Immunosuppressive treatment; Pure red cell aplasia

Indexed keywords

CYCLOSPORIN; CYTARABINE; HEMOGLOBIN; IDARUBICIN; PREDNISONE;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; BLOOD CELL COUNT; BONE MARROW BIOPSY; BONE MARROW EXAMINATION; BONE MARROW TRANSPLANTATION; CASE REPORT; CAUSE OF DEATH; CHRONIC MYELOMONOCYTIC LEUKEMIA; DEATH; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTOSIS; LIVER FAILURE; MONOCYTOSIS; PHYSICAL EXAMINATION; PURE RED CELL ANEMIA; SIBLING; THROMBOCYTOPENIA; TREATMENT RESPONSE;

CELL TRANSFORMATION, NEOPLASTIC; CYCLOSPORINE; DISEASE PROGRESSION; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MIDDLE AGED; RED-CELL APLASIA, PURE; STEROIDS;

EID: 73449110480     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-009-0423-1     Document Type: Article

References (17)

1. K Sawada N Fujishimai M Hirokawai 2008 Acquired pure red cell aplasia: updated review of treatment Brit J Haem 142 505 514 10.1111/j.1365-2141.2008. 07216.x 1:CAS:528:DC%2BD1cXhtV2qsLnK (Pubitemid 352020200)
2. C Ustün H Celebi M Arat M Ozcan I Dilek G Gürman, et al. 1999 Treatment of aregeneratoric anemia following an ABO-incompatible allogeneic peripheral blood stem cell transplantation: a case report Ther Apher 3 275 277 10.1046/j.1526-0968.1999.00135.x 10427629 (Pubitemid 29353134)
3. C Ustün D Karavelioǧlu O Ilhan O Aydintug M Beksac 1997 A case report of a patient who has pure red cell aplasia and rheumatoid arthritis Int J Hematol 66 505 512 10.1016/S0925-5710(97)00061-3 9479876
4. F Gilsanz J Garcia Vela JA Vargas J Ibañez F Ona J Lopez M Roqqendorf 1995 Acquired pure red cell aplasia: a study of six cases Ann Hematol 71 181 183 10.1007/BF01910315 1:STN:280:DyaK28%2FosV2hsw%3D%3D 7578524
5. A López-Guillermo F Cervantes E Sacanella L Florensa C Rozman 1989 Pure red cell aplasia associated with chronic myelomonocytic leukaemia Clin Lab Haematol 11 410 411 10.1111/j.1365-2257.1989.tb00243.x 2514066 (Pubitemid 20026880)
6. PH Bolton-Maggs MJ Galloway EG Rhodes 1989 Pure red cell aplasia heralding chronic myelomonocytic leukaemia Clin Lab Haematol 11 61 65 10.1111/j.1365-2257.1989.tb00176.x 1:STN:280:DyaL1M3gvFKjtw%3D%3D 2495882
7. DA Francis 1982 Pure red cell aplasia: association with systemic lupus erythematosus and primary autoimmune hypothyroidism Br Med J 284 85 10.1136/bmj.284.6309.85 1:STN:280:DyaL38%2Fpt1yitw%3D%3D
8. AP Grigg E O'Flaherty 2001 Cyclosporin A for the treatment of pure red cell aplasia associated with myelodysplasia Leuk Lymph 42 1339 1342 10.3109/10428190109097761 1:STN:280:DC%2BD387nsl2muw%3D%3D
9. T Yamauchi H Shirasaki A Kuwata T Yamashita S Imamura H Tsutani T Ueda 2002 Pure red cell aplasia developing into myeloproliferation with myelodysplasia and subsequent leukemia after Cyclosporin A therapy Int J Hematol 75 514 518 10.1007/BF02982116 12095153
10. Orazi A, Bennet JM, Germin U, et al. Chronic myelomonocytic leukemia. In: Swerdlow SH, Campo E, Harris NL, et al., editors. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. 4th ed. France: Lyon; 2008:76.
11. A Orazi U Germing 2008 The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features Leukemia 22 1308 1319 10.1038/leu.2008.119 1:STN:280:DC%2BD1cvltFCmuw%3D%3D 18480833
12. JM Ribera F Cervantes C Rozman 1987 A multivariate analysis of prognostic factors in chronic myelomonocytic leukemia according to FAB criteria Br J Haematol 65 307 311 10.1111/j.1365-2141.1987.tb06858.x 1:STN:280: DyaL2s7osFalsw%3D%3D 3471268
13. DL Barnard GF Burns J Gordon JC Cawley CR Barker FG Hayhoe, et al. 1979 Chronic myelomonocytic leukemia with paraproteinemia but no plasmacytosis. A detailed cytological and immunological study Cancer 44 927 936 10.1002/1097-0142(197909)44:3<927::AID-CNCR2820440321>3.0.CO;2-O 1:STN:280:DyaL3c%2FgtFGmug%3D%3D 113079 (Pubitemid 10242225)
14. P Solal-Celigny B Desaint A Herrera M Amar M Vroclans N Brousse, et al. 1984 Chronic myelomonocytic leukemia according to FAB classification: analysis of 35 cases Blood 63 634 638 1:STN:280:DyaL2c7ivV2hsA%3D%3D 6582939
15. P Greenberg C Cox MM LeBeau P Fenaux P Morel G Sanz, et al. 1997 International scoring system for evaluating prognosis in myelodysplastic syndromes Blood 89 2079 2088 1:CAS:528:DyaK2sXhvVars70%3D 9058730
16. F Onida HM Kantarjian TL Smith G Ball MJ Keating EH Estey, et al. 2002 Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients Blood 99 840 849 10.1182/blood.V99.3.840 1:CAS:528:DC%2BD38XhtValsLk%3D 11806985 (Pubitemid 34525544)
17. C Aul N Gattermann A Heyll U Germing G Derigs W Schneider 1992 Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system Leukemia 6 52 59 1:STN:280: DyaK387jvF2gtA%3D%3D 1736014